MDxHealth SA ADR

Company Profile

MDxHealth SA ADR had its IPO on 2021-11-04 under the ticker symbol MDXH.

The company operates in the Healthcare sector and Diagnostics & Research industry. MDxHealth SA ADR has a staff strength of 252 employees.

Stock update

Shares of MDxHealth SA ADR opened at $3.04 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.04 - $3.33, and closed at $3.14.

This is a +2.61% increase from the previous day's closing price.

A total volume of 18,516 shares were traded at the close of the day’s session.

In the last one week, shares of MDxHealth SA ADR have slipped by -3.09%.

MDxHealth SA ADR's Key Ratios

MDxHealth SA ADR has a market cap of $87.60 million, indicating a price to book ratio of 3.8583 and a price to sales ratio of 3.7352.

In the last 12-months MDxHealth SA ADR’s revenue was $55.49 million with a gross profit of $19.22 million and an EBITDA of $-28694000. The EBITDA ratio measures MDxHealth SA ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, MDxHealth SA ADR’s operating margin was -60.25% while its return on assets stood at -20.78% with a return of equity of -171.13%.

In Q2, MDxHealth SA ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 142.6%.

MDxHealth SA ADR’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.56 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into MDxHealth SA ADR’s profitability.

MDxHealth SA ADR stock is trading at a EV to sales ratio of 3.4935 and a EV to EBITDA ratio of -2.9967. Its price to sales ratio in the trailing 12-months stood at 3.7352.

MDxHealth SA ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$142.55 million

Total Liabilities

$41.37 million

Operating Cash Flow

$0

Capital Expenditure

$1.89 million

Dividend Payout Ratio

0%

MDxHealth SA ADR ended 2024 with $142.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $142.55 million while shareholder equity stood at $26.66 million.

MDxHealth SA ADR ended 2024 with $0 in deferred long-term liabilities, $41.37 million in other current liabilities, 173053000.00 in common stock, $-310681000.00 in retained earnings and $35.93 million in goodwill. Its cash balance stood at $39.47 million and cash and short-term investments were $39.47 million. The company’s total short-term debt was $1,967,000 while long-term debt stood at $35.18 million.

MDxHealth SA ADR’s total current assets stands at $51.73 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $8.10 million compared to accounts payable of $10.68 million and inventory worth $2.67 million.

In 2024, MDxHealth SA ADR's operating cash flow was $0 while its capital expenditure stood at $1.89 million.

Comparatively, MDxHealth SA ADR paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.14

52-Week High

$8.51

52-Week Low

$2.47

Analyst Target Price

$9.75

MDxHealth SA ADR stock is currently trading at $3.14 per share. It touched a 52-week high of $8.51 and a 52-week low of $8.51. Analysts tracking the stock have a 12-month average target price of $9.75.

Its 50-day moving average was $3.46 and 200-day moving average was $4.35 The short ratio stood at 0.98 indicating a short percent outstanding of 0%.

Around 30.8% of the company’s stock are held by insiders while 2978.8% are held by institutions.